Health Catalyst (HCAT) Receivables - Other (2018 - 2026)

Health Catalyst's Receivables - Other history runs 9 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• Quarterly Receivables - Other fell 15.58% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (down 15.58% YoY) and the FY2025 annual result came in at $10.1 million, down 14.41% from the prior year.
• Receivables - Other was $6.5 million for Q1 2026 at Health Catalyst, down from $10.1 million in the prior quarter.
• Across five years, Receivables - Other topped out at $11.8 million in Q4 2024 and bottomed at $500000.0 in Q2 2022.
• A 5-year average of $5.0 million and a median of $4.7 million in 2023 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2022 — Receivables - Other sank 58.33% — and 2023, when it jumped 422.22%.
• Health Catalyst's Receivables - Other stood at $900000.0 in 2022, then soared by 422.22% to $4.7 million in 2023, then jumped by 151.06% to $11.8 million in 2024, then retreated by 14.41% to $10.1 million in 2025, then tumbled by 35.64% to $6.5 million in 2026.
• Business Quant data shows HCAT's Receivables - Other at $6.5 million in Q1 2026, $10.1 million in Q4 2025, and $8.5 million in Q3 2025.